Astellas Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Astellas Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 6% to $1,603,672,000,000. Profit margin reached 1%. Total operating expenses were $1,285,669,000,000.
Profit Margin
| 2015 | 1.24T | 135.85B | 10.89% |
|---|---|---|---|
| 2016 | 1.37T | 193.68B | 14.11% |
| 2017 | 1.31T | 218.70B | 16.67% |
| 2018 | 1.30T | 164.67B | 12.66% |
| 2019 | 1.30T | 222.26B | 17.01% |
| 2020 | 1.30T | 195.41B | 15.02% |
| 2021 | 1.24T | 120.58B | 9.65% |
| 2022 | 1.29T | 124.08B | 9.57% |
| 2023 | 1.51T | 98.71B | 6.5% |
| 2024 | 1.60T | 17.04B | 1.06% |
ALPMY Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.60T | 1.51T | 1.29T | 1.24T | 1.30T | 1.30T | 1.30T | 1.31T | 1.37T | 1.24T |
Cost of revenue | 292.48B | 326.78B | 281.29B | 269.82B | 297.90B | 327.26B | 330.08B | 356.34B | 377.98B | 333.19B |
Gross profit | 1.31T | 1.19T | 1.01T | 979.70B | 1.00T | 979.08B | 970.22B | 955.32B | 994.72B | 914.06B |
Operating exp. | ||||||||||
Research and development | 294.2B | 276.12B | 246.01B | 224.48B | 224.22B | 208.68B | 220.78B | 208.12B | 225.66B | 206.6B |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.28T | 906.4B | 794.85B | 728.80B | 723.52B | 698.94B | 698.98B | 678.90B | 724.14B | 726.31B |
Operating income | 25.51B | 285.43B | 220.02B | 250.89B | 279.41B | 280.14B | 271.24B | 276.41B | 270.57B | 226.87B |
Other income (expenses), net | -549M | -668M | -63.62B | -106.05B | 3.01B | -31.17B | -53.12B | 5.35B | -8.80B | -37.19B |
Income before tax | 24.96B | 131.10B | 156.39B | 144.84B | 247.01B | 248.96B | 218.11B | 281.76B | 261.77B | 189.68B |
Income tax expense | 7.92B | 33.64B | 32.8B | 24.73B | 49.93B | 26.70B | 53.43B | 63.06B | 68.08B | 53.82B |
Net income | 17.04B | 98.71B | 124.08B | 120.58B | 195.41B | 222.26B | 164.67B | 218.70B | 193.68B | 135.85B |
Earnings per share | ||||||||||
Basic EPS | 9.47 | 54.24 | 67.08 | 64.93 | 104.15 | 115.05 | 81.11 | 103.69 | 89.62 | 61.4 |
Diluted EPS | 9.47 | 54.09 | 67.05 | 64.9 | 104.08 | 114.94 | 81.02 | 103.55 | 89.62 | 61.4 |